A Pharmacokinetic Study of Ustekinumab in Pediatric Subjects With Moderately to Severely Active Crohn's Disease
Clinical trial NCT02968108 · COMPLETED
Trial details
- NCT number
- NCT02968108
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-18
- Primary completion
- 2018-09-19
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.